Understanding hemolytic uremic syndrome in children
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study looks at how common hemolytic uremic syndrome (HUS) is in children. HUS is a rare condition that affects the blood and kidneys. The study helps doctors understand and identify this condition better in young patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The patient must be younger than 18 years old when diagnosed.
- A doctor must have confirmed hemolytic uremic syndrome (HUS), which includes three key signs: low red blood cells from breakage, low platelets, and kidney injury.
- The patient's medical records must be complete and confirm the diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how rare gene mutations may explain atypical HUS (aHUS) and how that could guide more personalized treatment. It mainly involves people who have had aHUS affecting blood counts and kidneys.
This is a registry that collects information from people diagnosed with atypical hemolytic uremic syndrome (aHUS). It helps researchers better understand the condition across different genetic causes and treatment needs.
This study tests a new medicine called INM004 in children with STEC-HUS, a serious illness that damages the kidneys and blood cells. It may help speed up recovery and prevent complications.
This trial uses special urine tests and a kidney MRI to find early signs of kidney damage in children with sickle cell disease. The goal is to detect kidney problems sooner so that treatment can start earlier and help protect kidney function.
This trial tests a way to use hydroxyurea more safely and effectively in children with sickle cell anemia. It may help doctors fine-tune dosing to reduce complications and side effects.
This study looks at children who come to the emergency room with visible blood in their urine (called gross hematuria). It tracks what causes it and how it is managed, which could help doctors give better care.
Hear when a new Prevalence of Hemolytic Uremic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.